| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 08/01/1996 | WO1996022769A1 Method for treating multiple sclerosis |
| 08/01/1996 | WO1996016052A3 Certain substituted 1-aryl-3-piperazin-1'-yl propanones |
| 08/01/1996 | WO1996013592A3 Protein kinase npk-110 |
| 08/01/1996 | CA2211608A1 Aza and aza (n-oxy) analogs of glycine/nmda receptor antagonists |
| 08/01/1996 | CA2210966A1 Bicyclic substituted hexahydrobenz[e]isoindole alpha-1- adrenergic antagonists |
| 08/01/1996 | CA2210662A1 Method for treating multiple sclerosis |
| 08/01/1996 | CA2210644A1 Ligands for eph-like receptors |
| 08/01/1996 | CA2210566A1 Method for treating multiple sclerosis |
| 07/31/1996 | EP0723959A1 Heterocyclic compounds as tachykinin receptor antagonists, process for their preparation and pharmaceuticals containing them |
| 07/31/1996 | EP0723546A1 1,2,4 - Triazolo (1,5-a) pyrimitives and their use for treatment of neurological disorders |
| 07/31/1996 | EP0723541A1 Indole derivatives as nmda antagonists |
| 07/31/1996 | EP0723460A1 Gene therapy of the nervous system |
| 07/31/1996 | EP0723454A1 Novel tripeptides useful in immune and cns therapy |
| 07/31/1996 | EP0723448A1 Use of peniclorin for the treatment of posttherapeutic neuralgia |
| 07/31/1996 | EP0723447A1 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
| 07/31/1996 | EP0723445A1 Analgesic agent and its use |
| 07/31/1996 | EP0723444A1 Levobupivacaine useful for managing chronic pain |
| 07/31/1996 | EP0723438A1 Substituted urea and isothiourea derivatives as no synthase inhibitors |
| 07/31/1996 | EP0550665B1 Novel neurothrophic factor |
| 07/31/1996 | CN1128030A Heterocyclic amines having central nervous system activity |
| 07/31/1996 | CN1127989A Improved nicotine lozenge and therapeutic method for smoking cessation |
| 07/31/1996 | CN1127749A Amino acid-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent and a medicament containing them |
| 07/31/1996 | CN1127640A Preparation for sobering up and preventing drunkenness and preparing method thereof |
| 07/30/1996 | US5541340 Method of preparing 1,2,3,3a,8,8a-hexahydro-3a,8(and 1,3a,8)-Di(and Tri)methylpyrrolo[2,3,-b] indoles |
| 07/30/1996 | US5541324 Anxiolytic agents, sedatives or hypnotic agents |
| 07/30/1996 | US5541319 Reacting substituted benzazepine ether with boron trihalide to form hydroxy group, forming salt with base if desired |
| 07/30/1996 | US5541228 Melatonergic agents |
| 07/30/1996 | US5541219 Antiinflammatory agents; aids |
| 07/30/1996 | US5541216 Memory enhancing and analgsic 1,2,3,3A,8,8A-Hexahydro--3A, 8(And1,3A,8)-Di (and Tri) Methylpyrrolo(2,3-B Indoles |
| 07/30/1996 | US5541208 Potassium channel antagonist, alzheimer*s disease and cognition activators |
| 07/30/1996 | US5541204 Aryloxypropanolamine β 3 adrenergic agonists |
| 07/30/1996 | US5541195 1-acylpiperidine compounds |
| 07/30/1996 | US5541194 Pharmaceutical compostion used to treat dementia |
| 07/30/1996 | US5541184 S-timolol hemihydrate treatment process |
| 07/30/1996 | US5541180 Headache therapy |
| 07/30/1996 | US5541164 Such as cladribine, to treat e.g. rheumatoid arthritis and multiple sclerosis |
| 07/30/1996 | US5540938 Formulations and their use in the treatment of neurological diseases |
| 07/30/1996 | CA1338494C 1,2,5,6-tetrahydropyridine oxime derivatives; process for preparing them and their use as drugs; compositions containing the same |
| 07/27/1996 | CA2141126A1 Combinational drug for treating migraine and other illnesses |
| 07/25/1996 | WO1996022369A1 Analogs of acidic fibroblast growth factor having enhanced stability and biological activity |
| 07/25/1996 | WO1996022306A1 Novel peptide |
| 07/25/1996 | WO1996022303A1 Therapeutic compound - fatty acid conjugates |
| 07/25/1996 | WO1996022295A1 Tricyclic benzazepine vasopressin antagonists |
| 07/25/1996 | WO1996022290A1 Compounds having effects on serotonin-related systems |
| 07/25/1996 | WO1996022108A1 The use of activated protein c for preparing a pharmaceutical preparation |
| 07/25/1996 | WO1996022104A1 Treatment of cerebral ischemia and cerebral damage with neuroprotective agent |
| 07/25/1996 | WO1996022091A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of cerebral degenerative disorders |
| 07/25/1996 | WO1996022068A2 Methods and pharmaceutical compositions employing desmethylselegiline |
| 07/25/1996 | CA2210632A1 Tricyclic benzazepine vasopressin antagonists |
| 07/25/1996 | CA2210500A1 Therapeutic compound - fatty acid conjugates |
| 07/25/1996 | CA2210220A1 Compounds having effects on serotonin-related systems |
| 07/25/1996 | CA2209931A1 The use of activated protein c for preparing a pharmaceutical preparation |
| 07/25/1996 | CA2208856A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of cerebral degenerative disorders |
| 07/24/1996 | EP0722942A1 Indole piperidine derivatives |
| 07/24/1996 | EP0722941A2 Compounds having effects on serotonin-related systems |
| 07/24/1996 | EP0722738A2 Vaccination and methods against diseases resulting from pathogenic responses by specific T cell populations |
| 07/24/1996 | EP0722737A1 Remedy for cranial nerve disorder |
| 07/24/1996 | EP0722734A1 NADH and NADPH therapeutic agents for nasal, sublingual, rectal and dermal administration |
| 07/24/1996 | EP0722730A1 Controlled release oxycodone compositions |
| 07/24/1996 | EP0722729A2 Aryl-substituted rhodanines for treating multiple sclerosis |
| 07/24/1996 | EP0722723A2 Phenol derivatives for treating multiple sclerosis |
| 07/24/1996 | EP0722496A1 Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative diseases |
| 07/24/1996 | EP0722457A1 Compounds modifying serotoninergic transmission, diagnostic and therapeutic applications |
| 07/24/1996 | EP0722434A1 Nitric esters having anti-inflammatory and/or analgesic activity and process for their preparation |
| 07/24/1996 | EP0722319A1 Anthracyclinone derivatives and their use in amyloidosis |
| 07/24/1996 | EP0722316A1 New emulsion formulation |
| 07/24/1996 | EP0714300A4 Methods for modulating the human sexual response |
| 07/24/1996 | CN1127509A New peptide derivatives |
| 07/24/1996 | CN1127472A Use of isovaleramide as a mild anxiolytic and mild sedative agent |
| 07/24/1996 | CN1127254A New 1,3-dihydro-2H-pyrrolo|2,3-b¨pyridin-2-one and oxazolo|4,5-b¨pyridin-2(3H)-one compounds, a process for their preparation and pharmaceutical compositions containing them |
| 07/24/1996 | CN1127252A Branched-amino-sbustituted thiazoles, processes for their preparation and the pharmaceutical compositions which contain them |
| 07/24/1996 | CN1127250A 2,3-bridged 1,4-dihydropyridines, process for their preparation and their use as medicaments |
| 07/24/1996 | CN1127247A New o-arylmethyl-N-(thio)acylhydroxylamines, process for preparing them and pharmaceutical compositions containing them |
| 07/24/1996 | CN1127116A New composition and subcompositions of same: process for obtaining them and their molecular identification, and their anti-inflammatory, analgesic, antipruritic and local antipyretic therapeutic effec |
| 07/24/1996 | CN1127114A Use of substituted 4-phenyl-6-amino-nicotinic acid derivatives as medicaments |
| 07/23/1996 | US5539000 Spray-chilled nabumetone |
| 07/23/1996 | US5538982 Medical use for tachykinin antagonists |
| 07/23/1996 | US5538981 5-hydroxytryptamine receptor antagonist activity |
| 07/23/1996 | US5538980 Central nervous system |
| 07/23/1996 | US5538972 Imidazoloquinoxalinones for the treatment of central nervous disorders |
| 07/23/1996 | US5538968 Alzheimer's disease |
| 07/23/1996 | US5538965 Dopamine receptor ligands |
| 07/23/1996 | US5538734 5-methyltetrahydrofolic acid, 5-formyl-tetrahydrofolic acid and their pharmaceutically acceptable salts for use in the therapy of depressive disturbances |
| 07/23/1996 | CA1338474C Pyridoindole derivatives and processes for preparation thereof |
| 07/23/1996 | CA1338473C Oxadiazolyl-azabicycloheptanes for the treatment of senile dementia |
| 07/18/1996 | WO1996021661A1 Piperidine derivatives having tachykinin antagonist activity |
| 07/18/1996 | WO1996021655A2 Substituted oxazolidine calpain and/or cathepsin b inhibitors |
| 07/18/1996 | WO1996021654A1 Novel compounds |
| 07/18/1996 | WO1996021644A1 Indole derivatives useful in the treatment of osteoporosis |
| 07/18/1996 | WO1996021641A1 Enantiomers of 1-(3,4-dichlorobenzyl)-2-methylaminoindane |
| 07/18/1996 | WO1996021452A1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine |
| 07/18/1996 | WO1996021446A1 Pharmaceutical composition with anti-alcoholic and nootropic properties |
| 07/18/1996 | WO1996021430A1 Treatment of attention-deficit/hyperactivity disorder |
| 07/18/1996 | WO1996003122A3 Use of gabapentin in the treatment of anxiety and panic |
| 07/18/1996 | CA2735293A1 Nadh and nadph therapeutic agents for dermal administration |
| 07/18/1996 | CA2210322A1 Novel compounds |
| 07/18/1996 | CA2209938A1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine |
| 07/18/1996 | CA2209936A1 Indole derivatives useful in the treatment of osteoporosis |
| 07/18/1996 | CA2167104A1 Nadh and nadph therapeutic agents for nasal, sublingual, rectal and dermal administration |
| 07/17/1996 | EP0721947A1 Alkyl(hetero)cyclic compounds, process for their preparation and pharmaceutical compositions containing them |